Effect of the Administration of L-Carnitine on Body Weight in Women in Crossfit Training

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-12-17

Study Completion Date

2019-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The L-carnitine has demonstrated effects in the treatment of obesity mainly promoting the fat degradation during exercise.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Oral Ketones and Exercise Among Patients With Long-chain Fatty Acid Oxidation Disorders

NCT05411835

Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency Carnitine Palmitoyltransferase Deficiency 2 Very Long Chain Acyl Coa Dehydrogenase Deficiency +1 more

COMPLETED EARLY_PHASE1

Acceptability and Tolerability of Ketone Supplements and Effects of BHB Concentrations in Young Adults

NCT05390385

Exogenous Ketosis

COMPLETED NA

The Effect of Different Ketone Supplements on β-OHB and Blood Glucose in Healthy Individuals

NCT05273411

Ketosis Blood Glucose

COMPLETED NA

Effects of Sweetness on Neurocognitive Responses, Glycemia and Food Intake

NCT03711084

Obesity

COMPLETED NA

Resistance Exercise, Recovery Drinks and Appetite

NCT02764177

Active Population

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A randomized, double-blind, placebo-controlled clinical trial will be carry out in 24 woman with body mass index ≥ 25 to 29.9 kg/m2. The patients will receive 1.5 g of L-Carnitine deluded in 250 ml of water or placebo before crossfit training, 5 times a week for 8 weeks. Before and after intervention the investigators evaluate: The body composition (body fat, lean body mass), arm muscle circumference, waist circumference, body weight and body mass index.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Body Weight Changes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo

Sucralose 1,5 g

Group Type PLACEBO_COMPARATOR

Sucralose

Intervention Type DIETARY_SUPPLEMENT

Sucralose 1.5 g diluted in 250 ml of water, before crossfit training, 5 times a week for 8 weeks

L-Carnitine

L- Carnitine 1,5 g

Group Type EXPERIMENTAL

L-Carnitine

Intervention Type DRUG

L-Carnitine oral solution 1.5 g diluted in 250 ml of water, before crossfit training, 5 times a week for 8 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

L-Carnitine

L-Carnitine oral solution 1.5 g diluted in 250 ml of water, before crossfit training, 5 times a week for 8 weeks

Intervention Type DRUG

Sucralose

Sucralose 1.5 g diluted in 250 ml of water, before crossfit training, 5 times a week for 8 weeks

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Levocarnitine Vitamin BT Trichlorogalacto-sucrose

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Volunteers who practice crossfit regularly (who have 3 months prior to the beginning of the study practicing crossfit).
* Volunteers with a body mass index equal to or greater than 25 Kg/m2.
* Volunteers who do not have allergies to L-Carnitine or any of its components.
* Informed consent signed
* Women with a recommendation of nutrition two weeks prior to the start of the study.
* Body weight stable the last 3 months.

Exclusion Criteria

* Volunteers with pathologies such as diabetes, hypertension, metabolic syndrome and allergies.
* Women with confirmed or suspected pregnancy.
* Women under lactation and/or puerperium.
* Hypersensibilility to L-Carnitine or Sucralose.
* Kown of renal, hepatic or thyroid deseased.
* Current or previous treatment diet (3 months before inclusion to the study).
* Current pharmacological treatment for loose body weight or 3 months before inclusion to the study.

Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes